Original Article

Bone and Soft Tissue Sarcoma Epidemiology in Iranian Elderly Population; an Analysis of the Iranian National Registry for Cancer (2009-2014 Years)

Abstract

Background: We aimed to investigate the patterns of incidence and prevalence of bone sarcoma (BS) and soft tissue sarcoma (STS), morphology as well as geographical distribution in the elderly in Iran.

Methods: By the primary site of the tumor and the morphological types, whole cases of cancer were classified. Then, the WHO classification (2018) and the third revision of the standard International Classification of Diseases for Oncology (ICD-O-3) were used to assign a code to them. The estimated incidence rates were obtained as the frequency of the newly-diagnosed cases within one year divided by the calculated population of the mid-year Iranian residents as estimated by the Iranian Bureau of Statistics. The age-standardized incidence rates were also estimated for both bone and soft tissue sarcoma.

Results: The annual crude incidence rates of sarcomas in males (0.80 per 100,000) were more than in females (0.55 per 100,000) in all years. The total combined crude incidence in 2014 years was obtained at 0.67 per 100,000 people. In terms of disease grade majority of the patients were of grade 3 (11.5 %). In terms of tumor location, the Lower extremity was 16.8%, the Visceral (including gastrointestinal & uterus) 15.8%, the Thoracic 12.8%, and the Pelvic & abdominal wall 9.7%.

Conclusion: Even though such sarcoma is more prevalent in elderly men, its incidence was also observed in lower-aged female groups. In addition, the incidence rate of BS was lower in comparison with that of STS, and the patients often exhibited an unknown degree of sarcoma.

1. Saltus CW, Calingaert B, Candrilli S, et al (2018). Epidemiology of adult soft-tissue sarcomas in Germany. Sarcoma, 2018:5671926.
2. Yaghmaii B, Nili F, Najafi Z, et al (2022). Renal involvement in a child with COVID-19 infection and its management with CRRT. Int J Prev Med, 13:19.
3. Hejazi S, Noroozi M, Kuhestani MA, et al (2020). Effective factors on clinical outcomes of children with osteosarcoma and Ewing bone tumors. Immunopathol Persa, 6(2):e26-e26
4. Sahraei Z, Panahi P, Solhjoukhah K, et al (2023). The Efficacy of High-Dose Pulse Therapy vs. Low-Dose Intravenous Methylprednisolone on Severe to Critical COVID-19 Clinical Outcomes: A Randomized Clinical Trial. Iran J Pharm Res, 22: e137838.
5. Garbay D, Maki R, Blay J, et al (2013). Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival. Ann Oncol, 24:1924-30.
6. Ebrahimpour A, Chehrassan M, Sadighi M, et al (2020). The survival and incidence rate of Ewing sarcoma; a national population-based study in Iran (2008-2015). Arch Bone Jt Surg, 8: 391–399.
7. Zabihiyeganeh M, Bozorgi MHA, Hatami S (2022). Multiple long bone fractures in a man with pycnodysostosis; a case report. Immunopathol Persa, 9:e24239-e.
8. Arabizadeh N, Zakerzadeh D, Nakhaie R, et al (2023). The pathology of brown tumor in a-36-year-old man on maintenance hemodialysis. J Parathyr Dis, 11:e11200.
9. Bray F, Ferlay J, Soerjomataram I, et al (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68:394-424.
10. Stiller C, Trama A, Serraino D, et al (2013). Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer, 49:684-95.
11. Asef-Kabiri L, Moradi A, Khayamzadeh M, et al (2021). Sarcomas Epidemiology in Iran: Analysis of Data from Iranian National Cancer Registry between 2009 and 2014. Int J Cancer Manag, 14: e110504.
12. Pingping B, Yuhong Z, Weiqi L, et al (2019). Incidence and mortality of sarcomas in Shanghai, China, during 2002–2014. Front Oncol, 9:662.
13. Hasanpour Dehkordi A, Keikhaei B, Bahadoram M, et al (2019). Keep the corners; impact of chemotherapy on renal function. J Nephropathol, 9: e02-e02.
14. Toumaj S (2023). Brown tumor in hyperparathyroidism; a new look at an old problem. J Parathyr Dis, 11:e11207.
15. Fletcher C, Bridge JA, Hogendoorn PCW, Mertens F (2013). WHO Classification of Tumours of Soft Tissue and Bone: WHO Classification of Tumours, 5:468.
16. Doyle LA (2014). Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone. Cancer, 120:1763-74.
17. Kleihues P, Cavenee W (2000). WHO classification of tumours. Pathology & genetics Tumors of the nervous system Lyon, France, IARCpress, 4:245.
18. Fletcher CD (2014). The evolving classification of soft tissue tumours–an update based on the new 2013 WHO classification. Histopathology, 64:2-11.
19. Hung G-Y, Horng J-L, Yen H-J, et al (2014). Incidence patterns of primary bone cancer in Taiwan (2003–2010): a population-based study. Ann Surg Oncol, 21:2490-8.
20. Bhatt N, Deady S, Gillis A, Bertuzzi A, et al (2016). Epidemiological study of soft‐tissue sarcomas in Ireland. Cancer Med, 5:129-35.
21. Yang Z, Zheng R, Zhang S, et al (2019). Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China. Cancer Biol Med, 16:565-574.
22. Burningham Z, Hashibe M, Spector L, Schiffman JD (2012). The epidemiology of sarcoma. Clin Sarcoma Res, 2:14.
23. Cardenas C (2023). Sarcomas: A comprehensive review of classification, diagnosis, treatment, and psychosocial aspects. Clin Oncol Case Rep, 6:2-8.
24. Gadgeel SM, Harlan LC, Zeruto CA, et al (2009). Patterns of care in a population‐based sample of soft tissue sarcoma patients in the United States. Cancer, 115:2744-54.
25. Brennan MF, Antonescu CR, Moraco N, Singer S (2014). Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg, 260:416-22.
26. Gage MM, Nagarajan N, Ruck JM, et al (2019). Sarcomas in the United States: Recent trends and a call for improved staging. Oncotarget, 10:2462-74.
27. Thomas DM, Savage SA, Bond GL (2012). Hereditary and environmental epidemiology of sarcomas. Clin Sarcoma Res, 2(1):13.
Files
IssueVol 53 No 7 (2024) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijph.v53i7.16061
Keywords
Bone sarcoma Soft tissue sarcoma Epidemiology Elderly Iran
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Akbari M-E, Fararouei M, Asef Kabiri L, Karami M, Gheibi Z, Nikeghbalian Z, Maki A, Bashirpour MA, Moradian F, Ghelichi-Ghojogh M. Bone and Soft Tissue Sarcoma Epidemiology in Iranian Elderly Population; an Analysis of the Iranian National Registry for Cancer (2009-2014 Years). Iran J Public Health. 2024;53(7):1670-1680.